{"auto_progress_calculation":true,"computation_units":"Percentage (%)","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":true,"data_start_values":[{"field":"Antigen or vaccine","value":"Diphtheria"},{"field":"Antigen or vaccine","value":"Tetanus"},{"field":"Antigen or vaccine","value":"Pertussis (whooping cough)"},{"field":"Geography","value":"Canada"},{"field":"Gender","value":"Women+"},{"field":"Gender","value":"Men+"}],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":["Geography"],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_titles":[{"series":"Diphtheria-tetanus-pertussis vaccine coverage at 2 years of age","title":"Diphtheria-tetanus-pertussis vaccine coverage at 2 years of age"},{"series":"Pneumococcal vaccine coverage at 2 years of age","title":"Pneumococcal vaccine coverage at 2 years of age"},{"series":"Measles vaccine coverage at 7 years of age","title":"Measles vaccine coverage at 7 years of age"},{"series":"Human Papillomavirus (HPV) vaccine coverage at 14 years of age","title":"Human Papillomavirus (HPV) vaccine coverage at 14 years of age"}],"graph_type":"line","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","indicator_number":"3.b.1","national_geographical_coverage":"Canada","page_content":"","permalink":"","precision":[],"progress_calculation_options":[{"direction":"positive","series":"Diphtheria-tetanus-pertussis vaccine coverage at 2 years of age","disaggregation":[{"field":"Antigen or vaccine","value":"Diphtheria"},{"field":"Geography","value":"Canada"}]},{"direction":"positive","series":"Pneumococcal vaccine coverage at 2 years of age"},{"direction":"positive","series":"Measles vaccine coverage at 7 years of age"},{"direction":"positive","series":"Human Papillomavirus (HPV) vaccine coverage at 14 years of age"}],"reporting_status":"complete","sort":"","standalone":false,"tags":["Proxy"],"proxy":"both","proxy_series":["Diphtheria-tetanus-pertussis vaccine coverage at 2 years of age"],"SDG_GOAL":"Goal 3: Ensure healthy lives and promote well-being for all at all ages","SDG_TARGET":"Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","SDG_INDICATOR":"Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme","STAT_CONC_DEF":"This indicator measures the childhood vaccination rates for selected diseases. The Public Health Agency of Canada routinely monitors childhood vaccination coverage in Canada through the childhood National Immunization Coverage Survey.","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"The childhood vaccines included were those that are publicly funded under provincial/territorial programs. The survey excluded First Nations on-reserve communities and institutionalized children.\n<br><br>\nDiphtheria-tetanus-pertussis vaccine coverage indicates the proportion of children having received the nationally recommended four doses by 2 years of age. This differs from the global metadata, which considers the proportion of the target population having received just three doses of diphtheria-tetanus-pertussis vaccine.\n<br><br>\nMeasles vaccine coverage indicates the proportion of 7-year-olds having received two doses of measles-containing vaccine.\n<br><br>\nPneumococcal coverage indicates four doses for 2-year-olds for the Northwest Territories and Nunavut, and three doses for the other provinces and territories. Data for pneumococcal coverage includes both penumococcal conjugate and pneumococcal polysaccharide vaccines.\n<br><br>\nHuman papillomavirus (HPV) vaccine coverage indicates the proportion of children having received one dose by 14 years of age. In 2024, the Public Health Agency of Canada updated its [HPV vaccine recommendations](https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-updated-recommendations-hpv-vaccines.html) from a two-dose schedule to a one-dose schedule for individuals 9 to 20 years of age.","PROGRESS_DETAILS":"The estimates for diphtheria coverage are used to measure progress in the proportion of the target population having received the recommended doses of the diphtheria-tetanus-pertussis vaccine.","SDG_GOAL__GLOBAL":"Goal 3: Ensure healthy lives and promote well-being for all at all ages","SDG_TARGET__GLOBAL":"Target 3.b: Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","SDG_INDICATOR__GLOBAL":"Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme","un_designated_tier":"Tier I","un_custodian_agency":"World Health Organization (WHO),  United Nations International Children's Emergency Fund (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata","source_active_1":true,"source_url_text_1":"Statistics Canada. Table 13-10-0870-01  Vaccine coverage estimates for recommended vaccines in children and pregnant women","source_url_1":"https://doi.org/10.25318/1310087001-eng","source_organisation_1":"Statistics Canada","source_periodicity_1":"Occasional","source_geographical_coverage_1":"Canada, provinces and territories","fr":{"SDG_GOAL":"Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.","SDG_TARGET":"Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments","SDG_INDICATOR":"Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national","STAT_CONC_DEF":"Cet indicateur mesure le taux de vaccination pour certaines maladies. L'Agence de la sant\u00e9 publique du Canada surveille la couverture vaccinale des enfants \u00e0 l'aide de l\u2019Enqu\u00eate nationale sur la couverture vaccinale des enfants.","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"Les vaccins pour enfants inclus dans l'ENCVE sont des vaccins financ\u00e9s par les fonds publics, dans le cadre des programmes de vaccination provinciaux et territoriaux. L'enqu\u00eate a exclu les enfants habitant dans les r\u00e9serves des Premi\u00e8res Nations et en \u00e9tablissement.\n<br><br>\nLa couverture vaccinale contre la dipht\u00e9rie, le t\u00e9tanos et la coqueluche indique la proportion d'enfants ayant re\u00e7u les quatre doses recommand\u00e9es nationalement par l'\u00e2ge de 2\u00a0ans. Cela diff\u00e8re des m\u00e9tadonn\u00e9es mondiales, qui consid\u00e8rent plutot la proportion de la population cible ayant re\u00e7u juste trois doses du vaccin contre la dipht\u00e9rie, le t\u00e9tanos et la coqueluche.\n<br><br>\nLa couverture vaccinale contre la rougeole indique la proportion des enfants \u00e2g\u00e9s de 7\u00a0ans ayant re\u00e7u deux doses d'un vaccin contre la rougeole.\n<br><br>\nLa couverture vaccinale contre le pneumocoque indique quatre doses pour les enfants de 2\u00a0ans dans les Territoires du Nord-Ouest et le Nunavut, et trois doses dans les autres provinces et territoires. Les donn\u00e9es pour la couverture vaccinale contre le pneumocoque incluent les vaccins conjugu\u00e9s et les vaccins polysaccharidiques.\n<br><br>\nLa couverture vaccinale contre le virus du papillome humain (VPH) indique la proportion d'enfants ayant re\u00e7u une dose avant l'\u00e2ge de 14\u00a0ans. En 2024, l'Agence de la sant\u00e9 publique du Canada a mis \u00e0 jour ses [recommandations en mati\u00e8re de vaccination contre le VPH](https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-updated-recommendations-hpv-vaccines.html), passant d'une vaccination \u00e0 deux doses \u00e0 une vaccination \u00e0 une dose pour les personnes \u00e2g\u00e9es de 9 \u00e0 20\u00a0ans.","PROGRESS_DETAILS":"Les estimations de la couverture contre la dipht\u00e9rie sont utilis\u00e9es pour mesurer les progr\u00e8s r\u00e9alis\u00e9s quant au pourcentage d\u2019enfants ayant re\u00e7u les doses recommand\u00e9es du vaccin contre la dipht\u00e9rie, le t\u00e9tanos et la coqueluche.","SDG_GOAL__GLOBAL":"Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.","SDG_TARGET__GLOBAL":"Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments","SDG_INDICATOR__GLOBAL":"Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national","un_designated_tier":"Niveau I","un_custodian_agency":"Organisation mondiale de la Sant\u00e9, Fonds des Nations Unies pour l'enfance (FISE)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"M\u00e9tadonn\u00e9es des objectifs de d\u00e9veloppement durable des Nations Unies","source_active_1":true,"source_url_text_1":"Statistique Canada. Tableau 13-10-0870-01  Estimation de la couverture vaccinale pour les vaccins recommand\u00e9s chez les enfants et les femmes enceintes","source_url_1":"https://doi.org/10.25318/1310087001-fra","source_organisation_1":"Statistique Canada","source_periodicity_1":"Occasionnelle","source_geographical_coverage_1":"Canada, Province et territoire"},"national_metadata_updated_date":"2025-09-15","national_data_updated_date":"2025-09-15","target_number":"3.b","goal_number":"3","indicator_sort_order":"03-0b-01","graph_title":"Proportion of the target population covered by all vaccines included in their national programme","progress_status":"limited_progress"}